Dr. Paul Billings, CEO and Kevin Han, CFO are scheduled to participate in a fireside chat with UBS analysts on Wednesday, August 10th at 1:00 p.m. ET / 10:00 a.m. PT. Webcast link

This three-day event will once again bring together key industry executives, institutional investors and UBS professionals from across the Genomics and MedTech sectors. Our carefully-curated agenda will include exclusive keynote speakers and thematic panel discussions in addition to presentations from a select group of high-quality, Genomics and MedTech Innovations companies. In addition, investors will have the opportunity to dialogue directly with corporates and management teams through one-on-one and small